Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MENINGOCOCCAL infections"" wg kryterium: Temat


Tytuł :
Information needs during an emerging outbreak of meningococcal W135 disease in the Netherlands: a study among teenagers, their parents and healthcare professionals.
Autorzy :
de Vries M; National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, Netherlands. .
Çoban FR; National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, Netherlands.
Claassen L; National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control / Center for Environmental Safety and Security, Bilthoven, Netherlands.
Te Wierik MJM; National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, Netherlands.
Timmermans DRM; Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Timen A; National Institute for Public Health and the Environment (RIVM), Center for Infectious Disease Control, Bilthoven, Netherlands.; VU University Amsterdam, Athena Institute for Research on Innovation and Communication in Health and Life Sciences, Amsterdam, Netherlands.
Pokaż więcej
Źródło :
BMC public health [BMC Public Health] 2021 Aug 12; Vol. 21 (1), pp. 1540. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
General Practitioners*
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Adolescent ; Delivery of Health Care ; Disease Outbreaks ; Humans ; Netherlands/epidemiology ; Parents ; Vaccination ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
Autorzy :
McMillan M; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Chandrakumar A; Central Adelaide Local Health Network, South Australia Health, Adelaide, South Australia, Australia.
Wang HLR; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Clarke M; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Sullivan TR; SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, South Australia,Australia.; School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
Andrews RM; Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
Ramsay M; Immunisation Department, Public Health England, London, United Kingdom.
Marshall HS; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 02; Vol. 73 (3), pp. e609-e619.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
Neisseria meningitidis, Serogroup B*
Humans ; Infant ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Lessons for and from the COVID-19 pandemic response - An appraisal of guidance for the public health management of Invasive Meningococcal Disease.
Autorzy :
Morello BR; School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia.
Milazzo A; School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia.
Marshall HS; Adelaide Medical School, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace & George Street, Adelaide, SA 5005, Australia; Robinson Research Institute, The University of Adelaide, Ground Floor, Norwich Centre, 55 King William Road, North Adelaide, SA 5006, Australia.
Giles LC; School of Public Health, The University of Adelaide, Adelaide Health and Medical Sciences Building, Corner of North Terrace and George Street, Adelaide, SA 5005, Australia; Robinson Research Institute, The University of Adelaide, Ground Floor, Norwich Centre, 55 King William Road, North Adelaide, SA 5006, Australia. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and public health [J Infect Public Health] 2021 Aug; Vol. 14 (8), pp. 1069-1074. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Europe ; Humans ; Pandemics ; Public Health ; SARS-CoV-2 ; United Kingdom
Czasopismo naukowe
Tytuł :
Meningococcal vaccines in China.
Autorzy :
Xu Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Li Y; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Wang S; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Li M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Xu M; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Ye Q; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes of Food and Drug Control, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2197-2204. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningitis, Meningococcal*/epidemiology
Meningitis, Meningococcal*/prevention & control
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
China/epidemiology ; Humans ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
Autorzy :
Fazio C; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Biolchi A; GSK, Siena, Italy.
Neri A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Tomei S; GSK, Siena, Italy.
Vacca P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Ambrosio L; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Palmieri A; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Mori E; GSK, Siena, Italy.
La Gaetana R; GSK, Siena, Italy.
Pizza M; GSK, Siena, Italy.
Giuliani MM; GSK, Siena, Italy.
Serino L; GSK, Siena, Italy.
Stefanelli P; Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2225-2231. Date of Electronic Publication: 2021 Jan 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*/genetics
Neisseria meningitidis, Serogroup B*/genetics
Adolescent ; Antigens, Bacterial/genetics ; Humans ; Infant ; Italy/epidemiology ; Serogroup
Czasopismo naukowe
Tytuł :
Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.
Autorzy :
Dubey AP; Pediatrics, ESI-PGIMSR & Model Hospital, New Delhi, India.
Hazarika RD; Pediatrics, Nemcare Superspeciality Hospital, Bhangagarh, Guwahati, and RIGPA Children's Clinic, Guwahati, India.
Abitbol V; GSK, Rueil-Malmaison, France.
Kolhapure S; GSK, Mumbai, India.
Agrawal S; GSK, New Delhi, India.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2216-2224. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
Adolescent ; Disease Outbreaks ; Humans ; India/epidemiology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination.
Autorzy :
Martinón-Torres F; Hospital Clínico Universitario de Santiago de Compostela and University of Santiago, A Choupana, s/n, 15706 Santiago de Compostela, Spain.
Banzhoff A; GSK, Emil-von-Behring-Strasse 76, 35041 Marburg, Germany. Electronic address: .
Azzari C; University of Florence, Dipartimento di Scienze della Salute, Florence, Italy.
De Wals P; Department of Social and Preventive Medicine, Laval University, Division of Biological Risks and Occupational Health, Quebec National Public Health Institute (Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec), and Quebec University Hospital Research Centre, Quebec City, Canada.
Marlow R; Bristol Medical School, University of Bristol, Bristol, BS8* 2PS, United Kingdom.
Marshall H; VIRTU, Women's and Children's Health Network & Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
Pizza M; GSK, via Fiorentina 1, 53100 Siena, Italy.
Rappuoli R; GSK, via Fiorentina 1, 53100 Siena, Italy.
Bekkat-Berkani R; GSK, Rockville, MD, USA.
Pokaż więcej
Źródło :
The Journal of infection [J Infect] 2021 Jul; Vol. 83 (1), pp. 17-26. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Video-Audio Media
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*
Adolescent ; Child ; Child, Preschool ; Humans ; Immunization Programs ; Infant ; Vaccination
Czasopismo naukowe
Tytuł :
Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in Adolescents.
Autorzy :
McMillan M; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Walters L; Microbiology and Infectious Diseases Directorate, South Australia Pathology, Adelaide, South Australia, Australia.
Sullivan T; South Australian Health and Medical Research Institute Women and Kids, Adelaide, South Australia, Australia.; School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
Leong LEX; Microbiology and Infectious Diseases Directorate, South Australia Pathology, Adelaide, South Australia, Australia.
Turra M; Microbiology and Infectious Diseases Directorate, South Australia Pathology, Adelaide, South Australia, Australia.
Lawrence A; Microbiology and Infectious Diseases Directorate, South Australia Pathology, Adelaide, South Australia, Australia.
Koehler AP; Communicable Disease Control Branch, SA Health, Adelaide, South Australia, Australia.
Finn A; Bristol Children's Vaccine Centre, School of Cellular and Molecular Medicine and School of Population Health Sciences, University of Bristol, Bristol, England.
Andrews RM; Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.; National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
Marshall HS; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. e99-e106.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
Adolescent ; Australia/epidemiology ; Carrier State/epidemiology ; Carrier State/prevention & control ; Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents.
Autorzy :
McMillan M; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Wang B; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Koehler AP; Communicable Disease Control Branch, SA Health, Adelaide, South Australia, Australia.
Sullivan TR; South Australian Health and Medical Research Institute Women and Kids, South Australian Health and Medical Research Institute, Adelaide, Australia.; School of Public Health, University of Adelaide, Adelaide, South Australia, Australia.
Marshall HS; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia.; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. e233-e237.
Typ publikacji :
Journal Article; Observational Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis*
Neisseria meningitidis, Serogroup B*
Adolescent ; Adult ; Humans ; Infant ; South Australia/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.
Autorzy :
Subbarao S
Campbell H
Ribeiro S
Clark SA
Lucidarme J
Ramsay M
Borrow R
Ladhani S
Pokaż więcej
Źródło :
Emerging infectious diseases [Emerg Infect Dis] 2021 Sep; Vol. 27 (9), pp. 2495-2497. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Meningococcal Infections*/epidemiology
Meningococcal Vaccines*
Neisseria meningitidis*
Communicable Disease Control ; England/epidemiology ; Humans ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
Autorzy :
Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, Skejby, Palle Juul-Jensens Blvd 99, 8200 Aarhus N, Denmark. Electronic address: .
Vesikari T; Nordic Research Network Ltd, Biokatu 10, 33520 Tampere, Finland.
Senders SD; Senders Pediatrics, 2054 South Green Road, South Euclid, OH, USA.
Flodmark CE; Department of Pediatrics, Entrance 108, Skåne University Hospital in Malmö, 205 02 Malmö, Sweden.
Kosina P; Department of Infectious Diseases, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
Jiang HQ; Pfizer Vaccine Research and Development, 401 North Middletown Road, Pearl River, NY, USA.
Maguire JD; Pfizer Vaccine Research and Development, 401 North Middletown Road, Pearl River, NY, USA.
Absalon J; Pfizer Vaccine Research and Development, 401 North Middletown Road, Pearl River, NY, USA.
Jansen KU; Pfizer Vaccine Research and Development, 401 North Middletown Road, Pearl River, NY, USA.
Harris SL; Pfizer Vaccine Research and Development, 401 North Middletown Road, Pearl River, NY, USA.
Maansson R; Pfizer Vaccine Research and Development, 500 Arcola Road, Collegeville, PA, USA.
Balmer P; Pfizer Vaccine Medical and Scientific Affairs, 500 Arcola Road, Collegeville, PA, USA.
Beeslaar J; Pfizer UK Vaccine Research and Development, Horizon Building, Honey Lane, Hurley SL6 6RJ, UK.
Perez JL; Pfizer Vaccine Research and Development, 500 Arcola Road, Collegeville, PA, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 22; Vol. 39 (32), pp. 4545-4554. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*/adverse effects
Neisseria meningitidis, Serogroup B*
Adolescent ; Antibodies, Bacterial ; Humans ; Immunogenicity, Vaccine ; Serogroup
Czasopismo naukowe
Tytuł :
Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision.
Autorzy :
Oostdijk C; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, the Netherlands. Electronic address: .
Van Zoonen K; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, the Netherlands.
Ruijs WLM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, the Netherlands.
Mollema L; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, the Netherlands.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 13; Vol. 39 (31), pp. 4283-4290. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Adolescent ; Humans ; Netherlands ; Parents ; Vaccination ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China.
Autorzy :
Wang X; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China.
Xia A; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China.
Wang C; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China.
Tian H; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China.
Chang H; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China.
Zeng M; Department of Infectious Diseases, Children's Hospital of Fudan University, Shanghai, PR China. Electronic address: .
Chen M; Department of Microbiology, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR China; Department of Microbiology, Shanghai Institutes of Preventive Medicine, Shanghai, PR China. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 13; Vol. 39 (31), pp. 4261-4265. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/diagnosis
Meningococcal Vaccines*
Neisseria meningitidis*
Child ; Child, Preschool ; China ; Finland ; Humans ; Italy ; Male ; Serogroup ; South Africa
Czasopismo naukowe
Tytuł :
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccines.
Autorzy :
Serra L; Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Knuf M; Dr. Horst Schmidt Clinic, Children's Hospital, Wiesbaden, Germany, and Pediatric Infectious Diseases, University Medicine, Mainz, Germany.
Martinón-Torres F; Pediatrics Department, Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Pediatrics Research Group, University of Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Yi K; Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Findlow J; Vaccine Medical, Development, Scientific and Clinical Affairs, Pfizer Ltd, Tadworth, UK.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2205-2215. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Animals ; Antibodies, Bacterial ; Immunity ; Rabbits ; Serogroup ; Vaccines, Conjugate
Czasopismo naukowe
Tytuł :
Meningococcus, this famous unknown.
Autorzy :
Dos Santos Souza I; CNRS, UMR8104, Paris, France.; Inserm, U1016, Institut Cochin, Paris, France.; Université de Paris, Faculté de Santé, France.
Ziveri J; Inserm, U1016, Institut Cochin, Paris, France.; Inserm, U1016, Institut Cochin, Paris, France.; Université de Paris, Faculté de Santé, France.
Bouzinba-Segard H; Inserm, U1016, Institut Cochin, Paris, France.; Inserm, U1016, Institut Cochin, Paris, France.; Université de Paris, Faculté de Santé, France.
Morand P; Inserm, U1016, Institut Cochin, Paris, France.; Inserm, U1016, Institut Cochin, Paris, France.; Université de Paris, Faculté de Santé, France.
Bourdoulous S; Inserm, U1016, Institut Cochin, Paris, France.; Inserm, U1016, Institut Cochin, Paris, France.; Université de Paris, Faculté de Santé, France.
Pokaż więcej
Źródło :
Comptes rendus biologies [C R Biol] 2021 Jul 02; Vol. 344 (2), pp. 127-143. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article
MeSH Terms :
Meningococcal Infections*/drug therapy
Neisseria meningitidis*
Purpura Fulminans*/drug therapy
Anti-Bacterial Agents ; Humans
Czasopismo naukowe
Tytuł :
Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities.
Autorzy :
Meiring S; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Cohen C; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
de Gouveia L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
du Plessis M; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Ganesh K; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
Kleynhans J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
Quan V; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.
Tempia S; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. e28-e38.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/epidemiology
Meningococcal Infections*/epidemiology
Neisseria meningitidis*/genetics
Adolescent ; Carrier State/epidemiology ; Cross-Sectional Studies ; Female ; Humans ; Prevalence ; South Africa/epidemiology ; Students ; Universities
Czasopismo naukowe
Tytuł :
Recent increased incidence of invasive serogroup W meningococcal disease: A retrospective observational study.
Autorzy :
Hovmand N; Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Hvidovre Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark; Faculty of Human Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark. Electronic address: .
Lundbo LF; Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Hvidovre Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark. Electronic address: .
Kronborg G; Department of Infectious Diseases, Hvidovre Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark. Electronic address: .
Voss SS; Department of Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. Electronic address: .
Sandholdt H; Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Hvidovre Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark. Electronic address: .
Hoffmann S; Bacteria, Parasites & Fungi, Infectious Disease Preparedness, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. Electronic address: .
Valentiner-Branth P; Department of Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. Electronic address: .
Benfield T; Center of Research & Disruption of Infectious Diseases (CREDID), Department of Infectious Diseases, Hvidovre Hospital, Kettegaard Alle 30, 2650 Hvidovre, Denmark; Faculty of Human Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Jul; Vol. 108, pp. 582-587. Date of Electronic Publication: 2021 Jun 05.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Vaccines*
Neisseria meningitidis*
Aged ; Humans ; Incidence ; Retrospective Studies ; Serogroup
Czasopismo naukowe
Tytuł :
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program.
Autorzy :
Hall GC; Gillian Hall Epidemiology Ltd., London EN5 4ND, United Kingdom. Electronic address: .
Douglas I; London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom. Electronic address: .
Heath PT; St George's, University of London and St George's University Hospitals NHS Foundation Trust, London SW17 0QT, United Kingdom. Electronic address: .
Prabhakar P; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, United Kingdom. Electronic address: .
Rosillon D; GSK, 1300 Wavre, Belgium. Electronic address: .
Khan J; IQVIA, London N1 9JY, United Kingdom. Electronic address: .
Abbing-Karahagopian V; Global Clinical and Epidemiology R&D, GSK, 1101 CL Amsterdam, Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 02; Vol. 39 (24), pp. 3296-3303. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*/adverse effects
Neisseria meningitidis, Serogroup B*
Child ; Humans ; Infant ; United Kingdom/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
Meningococcal B vaccination coverage among older adolescents in the United States.
Autorzy :
La EM; RTI Health Solutions, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA. Electronic address: .
Garbinsky D; RTI Health Solutions, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA. Electronic address: .
Hunter S; RTI Health Solutions, 3040 E. Cornwallis Road, Research Triangle Park, NC 27709, USA. Electronic address: .
Poston S; GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA. Electronic address: .
Novy P; GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA.
Ghaswalla P; GSK, 5 Crescent Drive, Philadelphia, PA 19112, USA. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 May 06; Vol. 39 (19), pp. 2660-2667. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Meningococcal Infections*/epidemiology
Meningococcal Infections*/prevention & control
Meningococcal Vaccines*
Neisseria meningitidis, Serogroup B*
Adolescent ; Adult ; Cross-Sectional Studies ; Humans ; United States ; Vaccination ; Vaccination Coverage ; Young Adult
Czasopismo naukowe
Tytuł :
Tobacco smoking and meningococcal disease in adolescents and young adults: a systematic review and meta-analysis.
Autorzy :
Pilat EK; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, United Kingdom. Electronic address: .
Stuart JM; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, United Kingdom. Electronic address: .
French CE; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, United Kingdom; NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
The Journal of infection [J Infect] 2021 May; Vol. 82 (5), pp. 135-144. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Meningococcal Infections*/epidemiology
Neisseria meningitidis*
Adolescent ; Adult ; Child ; Child, Preschool ; Humans ; Odds Ratio ; Tobacco Smoking ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies